Crossmark

In-feed bambermycin medication induces anti-inflammatory effects and prevents parietal cell loss without influencing Helicobacter suis colonization in the stomach of mice

Crossref DOI link: https://doi.org/10.1186/s13567-018-0530-1

Published Online: 2018-04-10

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Witte, Chloë https://orcid.org/0000-0002-7632-105X
Taminiau, Bernard

Flahou, Bram

Hautekiet, Veerle

Daube, Georges

Ducatelle, Richard

Haesebrouck, Freddy
Funding

Funding for this research was provided by:

Huvepharma (40014429)

Special Research Fund of Ghent University (01D20414)
License Information

Text and Data Mining valid from 2018-04-10
More Information

Article History

Received: 22 January 2018

Accepted: 21 March 2018

First Online: 10 April 2018

Document is current

Any future updates will be listed below